Ernexa Therapeutics Inc (ERNA)

11:56 AM

Eterna therapeutics sees $394,174 stock acquisition by Charles Cherington - Investing.com India

11:56 AM

Apr 03, 2025

Ernexa Therapeutics Closes New Funding Round - GlobeNewswire

Apr 03, 2025

Apr 03, 2025

Biotech Breakthrough: Ernexa Secures $7.25M to Advance Revolutionary Cancer Treatment - Stock Titan

Apr 03, 2025

Mar 30, 2025

Brooklyn ImmunoTherapeutics (NYSE:BTX) Earns Hold Rating from Analysts at StockNews.com - MarketBeat

Mar 30, 2025

Mar 26, 2025

Eterna Therapeutics announces corporate rebranding to Ernexa Therapeutics By Investing.com - Investing.com Australia

Mar 26, 2025

Mar 26, 2025

Eterna Therapeutics announces corporate rebranding to Ernexa Therapeutics - Investing.com

Mar 26, 2025

Mar 25, 2025

Eterna Therapeutics Changes Name to Ernexa Therapeutics to - GlobeNewswire

Mar 25, 2025

Mar 25, 2025

Major Pivot: Eterna Becomes Ernexa, Unveils New Cancer and Autoimmune Disease Strategy - Stock Titan

Mar 25, 2025

Mar 22, 2025

Brooklyn ImmunoTherapeutics (NYSE:BTX) Coverage Initiated at StockNews.com - Defense World

Mar 22, 2025

Mar 18, 2025

StockNews.com Initiates Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX) - MarketBeat

Mar 18, 2025

Mar 14, 2025

Brooklyn ImmunoTherapeutics (NYSE:BTX) Coverage Initiated by Analysts at StockNews.com - Defense World

Mar 14, 2025

Mar 09, 2025

StockNews.com Begins Coverage on Brooklyn ImmunoTherapeutics (NYSE:BTX) - MarketBeat

Mar 09, 2025

Mar 08, 2025

Brooklyn ImmunoTherapeutics Inc (NYSE:BTX) Declares $0.09 Monthly Dividend - MarketBeat

Mar 08, 2025

Mar 07, 2025

Eterna Therapeutics sets annual meeting date, opens nominations - MSN

Mar 07, 2025

Feb 26, 2025

Better AI Stock: SoundHound AI vs. Broadcom - The Globe and Mail

Feb 26, 2025

Feb 26, 2025

Eterna Therapeutics Hosts Successful Inaugural Meeting with - GlobeNewswire

Feb 26, 2025

Feb 26, 2025

Can Eterna's Expert-Backed Cell Therapy Breakthrough Revolutionize Ovarian Cancer Treatment? - StockTitan

Feb 26, 2025

Feb 26, 2025

Brooklyn ImmunoTherapeutics (NYSE:BTX) Now Covered by Analysts at StockNews.com - Defense World

Feb 26, 2025

Feb 15, 2025

Eterna Therapeutics (NASDAQ:ERNA) & Galecto (NASDAQ:GLTO) Head to Head Comparison - Defense World

Feb 15, 2025

Feb 12, 2025

Eterna Therapeutics Inc (ERNA)’s highs and lows: A closer look at its stock price fluctuations - US Post News

Feb 12, 2025

Feb 11, 2025

Brooklyn ImmunoTherapeutics (NYSE:BTX) Now Covered by StockNews.com - Defense World

Feb 11, 2025

Feb 10, 2025

Ratio Examination: Eterna Therapeutics Inc (ERNA)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Feb 10, 2025

Feb 06, 2025

ERNA’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle

Feb 06, 2025

Feb 06, 2025

Eterna Therapeutics Inc (ERNA) is a good investment, but the stock may be undervalued - US Post News

Feb 06, 2025

Feb 05, 2025

Contrasting Eterna Therapeutics (NASDAQ:ERNA) and Anixa Biosciences (NASDAQ:ANIX) - Defense World

Feb 05, 2025

Feb 04, 2025

Market Insight: Eterna Therapeutics Inc (ERNA)’s Notable Drop, Closing at 0.36 - The Dwinnex

Feb 04, 2025

Jan 30, 2025

Eterna Therapeutics expands scientific board with oncology experts - MSN

Jan 30, 2025

Jan 30, 2025

Eterna Therapeutics’ Shares Surge After Promising Preclinical Results for ERNA-101 Cell Therapy - HPBL

Jan 30, 2025

Jan 28, 2025

Eterna Therapeutics expands scientific board with oncology experts By Investing.com - Investing.com Canada

Jan 28, 2025

Jan 28, 2025

Eterna Therapeutics Announces Expansion of Scientific Advisory Board - GlobeNewswire

Jan 28, 2025

Jan 16, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jan 16, 2025